Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Rel ...
Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate the Efficacy, Safety, and Tolerability of Three Doses of ACT-128800, an Oral S1P1 Receptor Agonist, Administered for Twenty-four Weeks in Patients With Relapsing-remitting Multiple Sclerosis Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Study to Eva ...